News About: Pharm. Industry
FTC to probe hospitals over rebates
Fair Trade Commission (FTC) Chairman Kwon Oh-seung implied on October 29 that the nation's antitrust body may further investigate major hospitals over unfair business practices involving pharmaceutical companies.
K...
Drug makes struggling to set up next year's business plan
Tougher anticorruption measures to be slapped by the Fair Trade Commission (FTC), along with the government's relentless slash on drug prices, are casting a shadow over drug makers' business program next year, fueling...
Winner is visible in Dong-A's management battle
The current management of Dong-A Pharmaceutical led by its incumbent Chairman Kang Shin-ho will be likely to win a nearly three-year bitter struggle between Kang Moon-seok, who replaced his father Kang Shin-ho as the ...
KPMA chairman calls for fair drug pricing policy
Kim Chung-soo of the Korea Pharmaceutical Manufacturers Association (KPMA) said in a statement that the government should work out measures to encourage drug companies to develop and market as many new drugs as possib...
Fair Trade Commission to slap fines on 10 pharmaceutical companies
The Fair Trade Commission (FTC) said on October 25 that 10 pharmaceutical firms have been found to provide hospitals and wholesalers with rebates or donations under various pretexts and that it will slap heavy fines o...
Local cold medicine market getting heated
With the winter season approaching in hand, local drug makers are biting into the domestic cold remedy market in hope of more proportions.
Some of the top three players, including Korean Drug, Hanil Pharm and Choon...
SeouLin seeks international hepatitis B test patent
SeouLin Bioscience, local biopharmaceutical firm, said it has filed an international patent application for detecting mutants of hepatitis B virus, a company official said.
The company's patent may be applicable in...
Current Dong-A management likely to win
Pharmaceutical sources says the current management led by its incumbent Chairman Kang Shin-ho will get more advantageous position as Mirae Asset Investments, the largest shareholder of Dong-A Pharmaceutical, announced...
Amino acid infusion makers struggling to boost bottom lines
The Korea's three drug makers for essential amino infusion Choongwae Pharm, CJ Corporation and Daehan Pharm - are finding it increasingly difficult to boost their bottom line amid extremely low prices compared with f...
Pharmacists and wholesalers shun returning old OTC-version Diane 35, Schering Korea says
Schering Korea is troubled by recovering the old stocks of Diane 35 that are shunned by pharmacists and wholesalers who desire to boost their sluggish sales.
Diane 35 was approved by the Korea Food and Drug Adminis...
